Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CNTA

Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTA
DateTimeSourceHeadlineSymbolCompany
10/14/20227:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/14/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
10/12/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/07/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
10/06/20225:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/05/202210:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Centessa Pharmaceuticals plc - CNTANASDAQ:CNTACentessa Pharmaceuticals PLC
10/04/20225:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/04/20225:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/04/20224:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
09/20/20228:33AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Poster Presentation Featuring Novel Orexin Receptor 2 (OX2R) Agonist Discovery Pipeline at the 26th Conference of the European Sleep Research Society (Sleep Europe 2022)NASDAQ:CNTACentessa Pharmaceuticals PLC
09/14/20229:44AMDow Jones NewsCentessa Gets FDA Orphan Designation for SerpinPC in Hemophilia BNASDAQ:CNTACentessa Pharmaceuticals PLC
09/14/20229:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Orphan Drug Designation Granted to SerpinPC for the Treatment of Hemophilia BNASDAQ:CNTACentessa Pharmaceuticals PLC
09/12/20227:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
09/12/20227:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Non-Human Primate Pharmacokinetic and Safety Data for LB101 (PD-L1xCD47) Demonstrating Potential for Enhanced Therapeutic IndexNASDAQ:CNTACentessa Pharmaceuticals PLC
08/29/20228:00AMGlobeNewswire Inc.Centessa Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:CNTACentessa Pharmaceuticals PLC
08/10/20226:59AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNTACentessa Pharmaceuticals PLC
08/10/20226:30AMGlobeNewswire Inc.Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2022; Provides Program Update for ZF874NASDAQ:CNTACentessa Pharmaceuticals PLC
07/25/20228:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Addition of Harris L. Rotman, PhD, as Senior Vice President of Regulatory AffairsNASDAQ:CNTACentessa Pharmaceuticals PLC
07/20/20226:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/15/202212:50PMTipRanksCentessa Pharmaceuticals (CNTA) Receives a Buy from Morgan StanleyNASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/06/20226:01PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNTACentessa Pharmaceuticals PLC
07/05/20227:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:CNTA